GE Healthcare has received FDA approval for its new mammography platform, the company reported.
The Senographe Essential is the next-generation of GE's Senographe full field digital mammography systems.
The new device will enhance image quality for physicians evaluating women for breast cancer. The Senographe Essential offers the largest active field of view in the industry with a 24 x 31 cm detector size, the company said. The foundation of the Senographe Essential imaging is GE's advanced digital detector, which at low doses delivers the industry's highest detective quantum efficiency, which is the most current standard for quantifying digital X-ray image quality, the company said.